KML Vision GmbH, a bioimage analysis software provider, and Phoenestra GmbH, specializing in stem cell bioprocessing, have initiated a collaborative venture.
Together, they aim to leverage the latest Artificial Intelligence (AI) technology for microscopy image analysis in bioprocess optimization and quality assurance, thus advancing the development of innovative stem cell-based products in the
Advancing Stem Cell Bioprocessing with AI
Induced pluripotent stem cells (iPSCs) offer immense potential for precision medicine. However, achie ...